You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

Citation Tools

Article menu

Download PDFPDF

Poster Presentation
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Schmetzer H, Stankova Z, Deen D, et al
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation
Journal for ImmunoTherapy of Cancer 2014;2:P10. doi: 10.1186/2051-1426-2-S2-P10